Investigating how beta amyloid interacts with adrenergic receptors in Alzheimer's disease
Beta amyloid-adrenergic receptor interaction in Alzheimer's Disease
This study is looking at how certain proteins related to Alzheimer's disease interact with specific receptors in the brain, hoping to find new ways to help improve thinking and memory for people living with the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-10695970 on NIH RePORTER |
What this research studies
This research focuses on understanding the interaction between beta amyloid peptides and adrenergic receptors in the context of Alzheimer's disease. It aims to explore how these interactions affect cognitive functions and contribute to the progression of the disease. By examining the cellular and molecular mechanisms involved, the study seeks to identify potential therapeutic targets that could lead to new treatments for Alzheimer's. The research employs in vivo models to assess the relevance of these findings in a living organism.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease who may benefit from new treatment approaches targeting beta amyloid interactions.
Not a fit: Patients with other forms of dementia or cognitive impairment unrelated to Alzheimer's disease may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel therapies that modify the progression of Alzheimer's disease.
How similar studies have performed: Other research has shown promise in targeting molecular interactions in Alzheimer's disease, suggesting that this approach could yield significant insights.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Wang, Qin — Augusta University
- Study coordinator: Wang, Qin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.